FAK and p53 Protein Interactions.
Anticancer Agents Med Chem., Sep;11(7):617-9 (2011)
A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [188.8.131.52(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonog
Carcinogenesis., May;33(5):1004-13 (2012)
Nanog increases focal adhesion kinase (FAK) promoter activity and expression and directly binds to FAK protein to be phosphorylated.
J. Biol. Chem., May;287(22):18656-73 (2012)
FAK overexpression and p53 mutations are highly correlated in human breast cancer.
Int. J. Cancer., Oct;125(7):1735-8 (2009)
Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo.
Cell Cycle., Jul;8(14):2266-80 (2009)
Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.
J. Med. Chem., Aug;52(15):4716-24 (2009)
A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer.
Cell Cycle., Aug;8(15):2435-43 (2009)
The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.
BMC Cancer., 9:280 (2009)
Society of surgical oncology presidential address: the war on cancer--shifting from disappointment to new hope.
Ann. Surg. Oncol., Aug;17(8):1971-8 (2010)
Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas.
Br. J. Cancer., Oct;72(4):986-91 (1995)
Altered expression of the retinoblastoma gene product in human sarcomas.
N. Engl. J. Med., Nov;323(21):1457-62 (1990)
Warren H. Cole, MD: visionary surgeon-scientist and mentor.
Surgery., Nov;130(5):891-2 (2001)
Overexpression of the focal adhesion kinase (p125FAK) in the vascular smooth muscle cells of intimal hyperplasia.
J. Vasc. Surg., Aug;34(2):344-9 (2001)
The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways.
J. Biol. Chem., Sep;275(39):30597-604 (2000)
Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes.
Clin. Cancer Res., Jun;6(6):2417-23 (2000)
The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells.
Cell Growth Differ., Dec;9(12):999-1005 (1998)
Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases.
Radiology., Oct;213(1):86-91 (1999)
The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996.
Cancer., Feb;88(4):912-20 (2000)
Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques.
J Magn Reson Imaging., 7(6):1040-7 (1997)
Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells.
Cell Growth Differ., Apr;7(4):413-8 (1996)